Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y
Signal Transduct Target Ther. 2025; 10(1):71.
PMID: 40025039
PMC: 11873319.
DOI: 10.1038/s41392-024-02081-y.
Fries L, Montrazi E, Allouche-Arnon H, Opazo F, Bar-Shir A, Frydman L
Nano Lett. 2025; 25(5):1758-1764.
PMID: 39841010
PMC: 11803745.
DOI: 10.1021/acs.nanolett.4c03036.
Mullerova M, Tarach P, Strasak T, Curinova P, Petrickovic R, Zavodna T
ACS Omega. 2025; 10(1):1047-1060.
PMID: 39829590
PMC: 11740622.
DOI: 10.1021/acsomega.4c08314.
Zhang H, Guo L, Li X, Liu H, Zhao Z, Ji G
ACS Omega. 2024; 9(49):48598-48606.
PMID: 39676924
PMC: 11635515.
DOI: 10.1021/acsomega.4c07442.
Kesharwani P, Halwai K, Jha S, Mughram M, Salman Almujri S, Almalki W
Mol Cancer. 2024; 23(1):244.
PMID: 39482651
PMC: 11526716.
DOI: 10.1186/s12943-024-02163-z.
Theoretical and Experimental Analyses of the Interfacial Mechanism of Dendrimer-Doxorubicin Complexes Formation.
Jachimska B, Goncerz M, Wolski P, Meldrum C, Lustyk L, Panczyk T
Mol Pharm. 2024; 21(11):5892-5904.
PMID: 39436101
PMC: 11539063.
DOI: 10.1021/acs.molpharmaceut.4c00941.
Charge-Reversal Nano-Drug Delivery Systems in the Tumor Microenvironment: Mechanisms, Challenges, and Therapeutic Applications.
Liang Y, Wu J, Yan Y, Wang Y, Zhao H, Wang X
Int J Mol Sci. 2024; 25(18).
PMID: 39337266
PMC: 11432038.
DOI: 10.3390/ijms25189779.
A Novel PAMAM G3 Dendrimer-Based Foam with Polyether Polyol and Castor Oil Components as Drug Delivery System into Cancer and Normal Cells.
Zareba M, Chmiel-Szukiewicz E, Uram L, Noga J, Rzepna M, Wolowiec S
Materials (Basel). 2024; 17(16).
PMID: 39203083
PMC: 11355831.
DOI: 10.3390/ma17163905.
Advances in nucleic acid therapeutics: structures, delivery systems, and future perspectives in cancer treatment.
Zhang L, Lou W, Wang J
Clin Exp Med. 2024; 24(1):200.
PMID: 39196428
PMC: 11358240.
DOI: 10.1007/s10238-024-01463-4.
Glucocorticoids-based prodrug design: Current strategies and research progress.
Liu H, Ji M, Xiao P, Gou J, Yin T, He H
Asian J Pharm Sci. 2024; 19(3):100922.
PMID: 38966286
PMC: 11222810.
DOI: 10.1016/j.ajps.2024.100922.
Anti-biofilm, drug delivery and cytotoxicity properties of dendrimers.
Ezeh C, Dibua M
ADMET DMPK. 2024; 12(2):239-267.
PMID: 38720923
PMC: 11075165.
DOI: 10.5599/admet.1917.
A Molecular Dynamics Simulation of Complexes of Fullerenes and Lysine-Based Peptide Dendrimers with and without Glycine Spacers.
Bezrodnyi V, Mikhtaniuk S, Shavykin O, Sheveleva N, Markelov D, Neelov I
Int J Mol Sci. 2024; 25(2).
PMID: 38255765
PMC: 10815860.
DOI: 10.3390/ijms25020691.
Progress in regulating inflammatory biomaterials for intervertebral disc regeneration.
Xiang H, Zhao W, Jiang K, He J, Chen L, Cui W
Bioact Mater. 2024; 33:506-531.
PMID: 38162512
PMC: 10755503.
DOI: 10.1016/j.bioactmat.2023.11.021.
A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs.
Lv L, Shi Y, Deng Z, Xu J, Ye Z, He J
Biomater Res. 2023; 27(1):133.
PMID: 38102651
PMC: 10722842.
DOI: 10.1186/s40824-023-00465-9.
Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer.
Zeng W, Luo Y, Gan D, Zhang Y, Deng H, Liu G
Front Bioeng Biotechnol. 2023; 11:1271420.
PMID: 38047286
PMC: 10693343.
DOI: 10.3389/fbioe.2023.1271420.
Nanoparticle-based materials in anticancer drug delivery: Current and future prospects.
Ajith S, Almomani F, Elhissi A, Husseini G
Heliyon. 2023; 9(11):e21227.
PMID: 37954330
PMC: 10637937.
DOI: 10.1016/j.heliyon.2023.e21227.
Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics.
Gajbhiye K, Salve R, Narwade M, Sheikh A, Kesharwani P, Gajbhiye V
Mol Cancer. 2023; 22(1):160.
PMID: 37784179
PMC: 10546754.
DOI: 10.1186/s12943-023-01849-0.
Advancements in Nanogels for Enhanced Ocular Drug Delivery: Cutting-Edge Strategies to Overcome Eye Barriers.
Lee H, Noh H
Gels. 2023; 9(9).
PMID: 37754399
PMC: 10529109.
DOI: 10.3390/gels9090718.
A pH-responsive bi-MIL-88B MOF coated with folic acid-conjugated chitosan as a promising nanocarrier for targeted drug delivery of 5-Fluorouracil.
Akbar M, Khattak S, Khan M, Saddozai U, Ali N, Alasmari A
Front Pharmacol. 2023; 14:1265440.
PMID: 37745070
PMC: 10517339.
DOI: 10.3389/fphar.2023.1265440.
Exploring the Potential of Lapatinib, Fulvestrant, and Paclitaxel Conjugated with Glycidylated PAMAM G4 Dendrimers for Cancer and Parasite Treatment.
Uram L, Wrobel K, Walczak M, Szymaszek Z, Twardowska M, Wolowiec S
Molecules. 2023; 28(17).
PMID: 37687164
PMC: 10489794.
DOI: 10.3390/molecules28176334.